Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Diabetes Care Electronic Pages

Response to Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417

  1. Ana I. Calleja, MD⇓ and
  2. Juan F. Arenillas, MD, PHD
  1. From the Stroke Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain; and the Department of Medicine, University of Valladolid, Valladolid, Spain
  1. Corresponding author: Ana I. Calleja, aicsanz{at}hotmail.com.
Diabetes Care 2012 Jun; 35(6): e50-e50. https://doi.org/10.2337/dc12-0430
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

We have read with interest the letter by Natarajan et al. (1) about our original article published in Diabetes Care (2). Our aim was to evaluate the prognostic effect of insulin resistance on the response to acute stroke thrombolysis. Insulin resistance was quantified with the homeostasis model assessment of insulin resistance (HOMA-IR) using fasting blood samples drawn 24–48 h after admission. We tried to design the study in a way that would minimize the potential confounding effect of hyperglycemia. First, on the basis of the results of the Glycemia in Acute Stroke study demonstrating that glycemia >155 mg/dL is an independent predictor of poor outcome in acute stroke patients (3), we excluded those patients with glucose concentration above this value on admission. Second, the logistic regression models were adjusted by admission glycemia. Previous literature on ischemic stroke had focused mainly on admission glycemia as one of the most robust predictors of poor outcome, and therefore we relied on this parameter to rule out this potential confounding effect. However, in agreement with the observation by Natarajan et al., the Glycemia in Acute Stroke study pointed to 155 mg/dL at any time within the first 48 h from stroke onset as the optimal glycemia cutoff level for good outcome at 3 month.

Attending the authors’ criticism, we checked the concentrations of glucose and insulin at 24–48 h in the groups of patients with good versus poor outcome. Both parameters were higher in the group of patients with a poor response to thrombolysis. Of note, mean glucose level in the poor outcome group was only modestly raised (124 mg/dL), in line with the idea that even mild increments of glycemia could be deleterious. We then conducted independent logistic regression models in which we included HOMA-IR, fasting glycemia, or insulin alone, and the association of HOMA-IR with poor outcome appeared to be more robust than the associations of HOMA-IR individual components. Thus, our results support the notion that insulin resistance itself may exert a deleterious effect in acute ischemic stroke. Nevertheless, from a methodological standpoint, it may be tremendously arduous to isolate the effects of insulin resistance and completely exclude a potential interference of glycemia. Trying to reconcile the observations of Natarajan et al. with our findings, one could argue that insulin resistance is a crucial factor contributing to more lasting and persistent high glucose levels during the acute phase of ischemic stroke. Finally, as stated in the limitations section, the results of our exploratory study warrant confirmation in a larger series.

Acknowledgments

A.I.C. was the recipient of a research grant from Instituto de Salud Carlos III (Río Hortega program), Ministry of Science, Spain (2008-2011), which was cofounded by Instituto de Salud Carlos III and Hospital Clínico Universitario, Salud Castilla y León (SACYL); Department of Health, Castilla y León (SACYL); and Gerencia Regional de Salud, Castilla y León (SACYL).

No potential conflicts of interest relevant to this article were reported.

  • © 2012 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

References

  1. 1.↵
    1. Natarajan S,
    2. Siddiqui A,
    3. Chaudhuri A,
    4. Dandona P
    . Comment on: Calleja et al. Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke. Diabetes Care 2011;34:2413–2417 (Letter). Diabetes Care 2012;35:e49. DOI: 10.2337/dc12-0083
  2. 2.↵
    1. Calleja AI,
    2. García-Bermejo P,
    3. Cortijo E,
    4. et al
    . Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke. Diabetes Care 2011;34:2413–2417
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Fuentes B,
    2. Castillo J,
    3. San José B,
    4. et al
    .; Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study. Stroke 2009;40:562–568
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Diabetes Care: 35 (6)

In this Issue

June 2012, 35(6)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Response to Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Response to Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
Ana I. Calleja, Juan F. Arenillas
Diabetes Care Jun 2012, 35 (6) e50; DOI: 10.2337/dc12-0430

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Response to Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
Ana I. Calleja, Juan F. Arenillas
Diabetes Care Jun 2012, 35 (6) e50; DOI: 10.2337/dc12-0430
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Acknowledgments
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Diabetes Care Electronic Pages

  • Comment on: Leeds et al. High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease. Diabetes Care 2011;34:2158–2163
  • Response to Comment on: Wheeler et al. Macronutrients, Food Groups, and Eating Patterns in the Management of Diabetes: A Systematic Review of the Literature, 2010. Diabetes Care 2012;35:434–445
  • Comment on: Calleja et al. Insulin Resistance Is Associated With a Poor Response to Intravenous Thrombolysis in Acute Ischemic Stroke. Diabetes Care 2011;34:2413–2417
Show more Diabetes Care Electronic Pages

Online Letters: Comments and Responses

  • Comment on Dalmas et al. Intima-Media Thickness in Severe Obesity: Links With BMI and Metabolic Status but Not With Systemic or Adipose Tissue Inflammation. Diabetes Care 2013;36:3793–3802
  • Comment on Khunti et al. Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411–3417
  • Response to Comment on Khunti et al. Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411–3417
Show more Online Letters: Comments and Responses

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.